Deep learning-based 3D quantitative total tumor burden predicts early recurrence of BCLC A and B HCC after resection
European Radiology · 2024
DOI: 10.1007/s00330-024-10941-y ↗Kurz gefasst
Fachartikel in der Zeitschrift European Radiology, 2024. Verfasst von Hong Wei und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Functional, and Molecular Imaging Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, Chengdu, Sich…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Deep Learning, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, the China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Objectives
This study aimed to evaluate the potential of deep learning (DL)-assisted automated three-dimensional quantitative tumor burden at MRI to predict postoperative early recurrence (ER) of hepatocellular carcinoma (HCC). Materials and methods This was a single-center retrospective study enrolling patients who underwent resection for BCLC A and B HCC and preoperative contrast-enhanced MRI. Quantitative total tumor volume (cm 3 ) and total tumor burden (TTB, %) were obtained using a DL automated segmentation tool. Radiologists’ visual assessment was used to ensure the quality control of automated segmentation. The prognostic value of clinicopathological variables and tumor burden-related parameters for ER was determined by Cox regression analyses.
Results
A total of 592 patients were included, with 525 and 67 patients assigned to BCLC A and B, respectively (2-year ER rate: 30.0% vs. 45.3%; hazard ratio (HR) = 1.8; p = 0.007). TTB was the most important predictor of ER (HR = 2.2; p < 0.001). Using 6.84% as the threshold of TTB, two ER risk strata were obtained in overall ( p < 0.001), BCLC A ( p < 0.001), and BCLC B ( p = 0.027) patients, respectively. The BCLC B low-TTB patients had a similar risk for ER to BCLC A patients and thus were reassigned to a BCLC A n stage; whilst the BCLC B high-TTB patients remained in a BCLC B n stage. The 2-year ER rate was 30.5% for BCLC A n patients vs. 58.1% for BCLC B n patients (HR = 2.8; p < 0.001).
Conclusions
TTB determined by DL-based automated segmentation at MRI was a predictive biomarker for postoperative ER and facilitated refined subcategorization of patients within BCLC stages A and B. Clinical relevance statement Total tumor burden derived by deep learning-based automated segmentation at MRI may serve as an imaging biomarker for predicting early recurrence, thereby improving subclassification of Barcelona Clinic Liver Cancer A and B hepatocellular carcinoma patients after hepatectomy. Key Points Total tumor burden (TTB) is important for Barcelona Clinic Liver Cancer (BCLC) staging, but is heterogenous. TTB derived by deep learning-based automated segmentation was predictive of postoperative early recurrence. Incorporating TTB into the BCLC algorithm resulted in successful subcategorization of BCLC A and B patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Functional, and Molecular Imaging Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.
- Department of Radiology, Seoul National University Hospital, Seoul, 03080, Republic of Korea.
- Shukun Technology Co., Ltd, Beijing, 100102, China.
- Big Data Research Center, University of Electronic Science and Technology of China, Chengdu, Sichuan, 610000, China.
- Department of Radiology, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea.
- Department of Radiology, Duke University Medical Center, Durham, NC, 27710, USA.
Förderung
- National Natural Science Foundation of China
- the China Postdoctoral Science Foundation
Zitieren
APA
Wei, H., Zheng, T., Zhang, X., Zheng, C., Jiang, D., Wu, Y., Lee, J. M., Bashir, M. R., Lerner, E., Liu, R., Wu, B., Guo, H., Chen, Y., Yang, T., Gong, X., Jiang, H., & Song, B. (2024). Deep learning-based 3D quantitative total tumor burden predicts early recurrence of BCLC A and B HCC after resection. European Radiology. https://doi.org/10.1007/s00330-024-10941-y
Vancouver
Wei H, Zheng T, Zhang X, Zheng C, Jiang D, Wu Y, et al. Deep learning-based 3D quantitative total tumor burden predicts early recurrence of BCLC A and B HCC after resection. European Radiology. 2024. doi:10.1007/s00330-024-10941-y
BibTeX
@article{Wei2024,
author = {Wei, Hong and Zheng, Tianying and Zhang, Xiaolan and Zheng, Chao and Jiang, Difei and Wu, Yuanan and Lee, Jeong Min and Bashir, Mustafa R and Lerner, Emily and Liu, Rongbo and Wu, Botong and Guo, Hua and Chen, Yidi and Yang, Ting and Gong, Xiaoling and Jiang, Hanyu and Song, Bin},
title = {Deep learning-based 3D quantitative total tumor burden predicts early recurrence of BCLC A and B HCC after resection},
journal = {European Radiology},
year = {2024},
doi = {10.1007/s00330-024-10941-y}
}
EUVIMED